NEW | Xcell™ Lab System
The XCell™ Lab system is designed and engineered as a complete solution. The XCell™ Lab system integrates.. NEED INTRO
- Engineering-designed controller promotes increased intensification
- Configurable set-up delivers high throughput - a single manifold supports up to 8 XCell ATF® devices
- Software enables precise technical control with a user-friendly interface
- New XCell ATF® 1 Device for low volume intensification ready for scale-up
- Repligen global technical support ensures successful implementation and scale-up
XCell™ Lab System
Fast and easy intensification that scales to manufacturing
DELIVER MORE,
FASTER
Increase throughput:
more programs,
more molecules
Increase productivity:
more product per batch
Increase capacity:
more batches per facility
TRANSFORM YOUR BUSINESS DECISIONS
Reduce bioreactor size,
especially < 2000L
Save > $250 million by solving facility-fit challenges
Alternative to facility expansion
- Lower cost
- Lower risk
- Faster results
XCELL™ LAB
CONTROLLER
Design simplicity:
software, hardware, device
Precision pumping enables robust development
More process data for improved characterization
Reduced media cost
How and why XCell ATF® Technology works
XCell ATF® 系统基于率获嘉奖的交替式 (ATF) 技术，其通过泵头内隔膜的上下移动过程而形成，泵连接至过滤器外壳，后者再连接至生物反应器。交替式切向流通过隔膜泵的作用而实现。
XCell ATF® Devices
100%细胞截留，安装加快80%，无需高压灭菌
100%细胞截留，高细胞密度和产物产量
The XCell ATF® Devices come in multiple sizes from lab-scale to production-scale. Each device consists of a proprietary diaphragm pump and a single-use hollow fiber filter module, for use with an XCell™ Controller.
Repligen在ISO 9001质量管理体系下开发和生产用于生物制药行业的产品。我们专注于及时交付高质量、一致且稳健的产品，以确保我们客户的业务连续性。
XCell ATF® intensification from Process development to manufacturing
XCell ATF® applications
UNDER CONSTRUCTION
REPLIGEN technical support ENSUres Success
The Repligen Field Application team with expertise in XCell ATF® technology will provide support from consultation to implementation globally.
咨询 |
评估 |
开发 |
使用 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
资源
Special Report on Continuous Bioprocessing: Upstream, Downstream, Ready for Prime Time?
WuXi Biologics Expands Perfusion Cell Culture Capabilities using ATF 10 System
Continuous Manufacturing: A Changing Processing Paradigm
Developing an upstream process for a monoclonal antibody including medium optimization
常见问题 | 灌流